Preimplantation genetic testing for Marfan syndrome

Marfan syndrome (MFS) is an autosomal dominant disease that affects the skeletal, ocular and cardiovascular systems. Defects in the gene that codes for fibrillin (FBN-1) are responsible for MFS. Here we report the world‘s first use of preimplantation genetic testing (PGT) to achieve a clinical pregn...

Full description

Saved in:
Bibliographic Details
Published in:Molecular human reproduction 1996-09, Vol.2 (9), p.713-715
Main Authors: Harton, G.L., Tsipouras, P., Sisson, M.E., Starr, K.M., Mahoney, B.S., Fugger, E.F., Schulman, J.D., Kilpatrick, M.W., Levinson, G., Black, S.H.
Format: Article
Language:English
Subjects:
Adult
Base Sequence
Blastomeres
Dinucleotide Repeats
DNA Primers - genetics
Embryo Transfer
Embryonic Development
Female
Fertilization in Vitro
Fibrillin-1
Fibrillins
Heterozygote
Homozygote
Humans
Infant, Newborn
linkage analysis
Male
Marfan syndrome
Marfan Syndrome - diagnosis
Marfan Syndrome - genetics
Microfilament Proteins - genetics
Mutation
Pedigree
Polymerase Chain Reaction
polymerase chain reaction (PCR)
Pregnancy
preimplantation genetic testing (PGT)
Prenatal Diagnosis - methods
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Marfan syndrome (MFS) is an autosomal dominant disease that affects the skeletal, ocular and cardiovascular systems. Defects in the gene that codes for fibrillin (FBN-1) are responsible for MFS. Here we report the world‘s first use of preimplantation genetic testing (PGT) to achieve a clinical pregnancy and live birth of a baby free of a Marfan mutation. One or two blastomeres from each embryo were tested for a CA repeat within the FBN-1 gene. The prospective mother is homozygous for the CA repeat (2/2) and has two normal copies of the FBN-1 gene, while the prospective father is heterozygous for the CA repeat (1/2), and is affected with the Marfan syndrome. In the father’s family, allele 2 segregates with the mutated FBN-1 gene. For PGT, any embryo diagnosed as heterozygous for the CA repeat (1/2) would be presumed to have inherited normal FBN-1 genes from the father and the mother and be unaffected. One in-vitro fertilization (IVF) cycle yielded 12 embryos for preimplantation testing; six of the embryos were heterozygous for the CA repeat (1/2) and presumed to be free of the Marfan mutation. Five of the six embryos were subsequently transferred into the uterus. The fetus was tested by chorionic villus sampling and found to be free of the Marfan mutation by the same linkage analysis, had a normal fetal echocardiogram, and was normal at birth.
ISSN:1360-9947
1460-2407
DOI:10.1093/molehr/2.9.713